Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.833 |
12 |
|
2011 |
2016 |
Diffuse mesangial sclerosis (disorder)
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
22
|
|
0.160 |
None |
1.000 |
6 |
|
2008 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2017 |
Steroid resistant nephrotic syndrome of childhood
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
73
|
19
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2017 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.030 |
None |
0.667 |
3 |
|
2013 |
2014 |
Steroid-resistant nephrotic syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
73
|
25
|
0.030 |
None |
1.000 |
3 |
|
2010 |
2017 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3926
|
712
|
0.030 |
None |
0.667 |
3 |
|
2014 |
2019 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2009 |
Hepatitis B
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1449
|
519
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
precancerous lesions
|
phenotype |
|
Neoplastic Process
|
270
|
19
|
0.020 |
None |
0.500 |
2 |
|
2016 |
2019 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
586
|
125
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
820
|
55
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Tumor Angiogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
822
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Viremia
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
56
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
stage, gastric cancer
|
phenotype |
|
Neoplastic Process
|
34
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Mitochondrial Respiratory Chain Deficiencies
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
49
|
3
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Miller Dieker syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
182
|
9
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
West Nile viral infection
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
164
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenocarcinoma, Tubular
|
disease |
Neoplasms
|
Neoplastic Process
|
133
|
3
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Carcinoma, Granular Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
116
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Carcinoma, Cribriform
|
disease |
Neoplasms
|
Neoplastic Process
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Adenocarcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
123
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |